SALTIRE-RAAVE: Targeting calcific aortic valve disease LDL-density-radius theory

SALTIRE and RAAVE were the first two studies to evaluate the use of statin therapy for impeding calcific aortic valve disease (CAVD). This review presents the findings of low-density lipoprotein (LDL)-density-radius theory as tested using the combined results from the SALTIRE and RAAVE studies. Patients who received statin therapy had a greater degree of LDL cholesterol lowering, seen as the % change in LDL (47 vs 2%, p ≥ 0.012), which in itself was significantly associated with a lesser change in aortic valve area (AVA; p < 0.001 and R² ≥ 0.27). The percent change in the AVA for the treated patients was 5% and 15% for the nontreated patients (p ≥ 0.579 and R² ≥ 0.03). In summary, these published findings suggest that when applying the LDL-density-radius theory, which combines the cellular biology and the hemodynamics as defined by the continuity equation for AVA, there may be a role for lipid-lowering therapy in contemporary patients with calcific aortic valve disease (CAVD).